CWM
Calamos Wealth Management’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,166
| Closed | -$241K | – | 317 |
|
2023
Q4 | $241K | Sell |
3,166
-1,649
| -34% | -$126K | 0.02% | 265 |
|
2023
Q3 | $334K | Sell |
4,815
-72
| -1% | -$4.99K | 0.03% | 240 |
|
2023
Q2 | $461K | Buy |
4,887
+1,665
| +52% | +$157K | 0.03% | 206 |
|
2023
Q1 | $267K | Sell |
3,222
-6,200
| -66% | -$513K | 0.02% | 268 |
|
2022
Q4 | $703K | Sell |
9,422
-52,331
| -85% | -$3.9M | 0.05% | 167 |
|
2022
Q3 | $5.1M | Buy |
61,753
+1,047
| +2% | +$86.5K | 0.44% | 59 |
|
2022
Q2 | $5.77M | Buy |
60,706
+1,492
| +3% | +$142K | 0.51% | 52 |
|
2022
Q1 | $6.97M | Buy |
59,214
+2,318
| +4% | +$273K | 0.52% | 48 |
|
2021
Q4 | $7.37M | Buy |
56,896
+1,118
| +2% | +$145K | 0.54% | 48 |
|
2021
Q3 | $6.32M | Buy |
55,778
+820
| +1% | +$92.8K | 0.51% | 51 |
|
2021
Q2 | $5.69M | Sell |
54,958
-3,660
| -6% | -$379K | 0.44% | 58 |
|
2021
Q1 | $4.9M | Buy |
58,618
+2,531
| +5% | +$212K | 0.4% | 69 |
|
2020
Q4 | $5.12M | Buy |
56,087
+4,549
| +9% | +$415K | 0.47% | 65 |
|
2020
Q3 | $4.11M | Buy |
51,538
+403
| +0.8% | +$32.2K | 0.47% | 60 |
|
2020
Q2 | $3.53M | Buy |
51,135
+34,782
| +213% | +$2.4M | 0.44% | 65 |
|
2020
Q1 | $3.09M | Buy |
16,353
+848
| +5% | +$160K | 0.47% | 59 |
|
2019
Q4 | $3.62M | Sell |
15,505
-65
| -0.4% | -$15.2K | 0.43% | 67 |
|
2019
Q3 | $3.42M | Sell |
15,570
-5,971
| -28% | -$1.31M | 0.46% | 67 |
|
2019
Q2 | $3.98M | Buy |
21,541
+1,161
| +6% | +$214K | 0.54% | 53 |
|
2019
Q1 | $3.9M | Sell |
20,380
-6,241
| -23% | -$1.19M | 0.56% | 50 |
|
2018
Q4 | $4.08M | Buy |
+26,621
| New | +$4.08M | 0.61% | 43 |
|
2017
Q1 | – | Sell |
-11,984
| Closed | -$1.12M | – | 243 |
|
2016
Q4 | $1.12M | Buy |
+11,984
| New | +$1.12M | 0.18% | 148 |
|